Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,229 total articles
Microsoft is trading off on macro and AI spending headlines, but its cash generation, margins, and modest leverage make the sell-off an overreaction. This is a mid-term swing trade: buy near current levels, target a recovery toward the $450 area, and use a tight stop under $380 to limit downside if the market keeps punishing capex narratives.
Nano Labs has moved from pure-play fabless chips toward cryptocurrency reserves and Web3 initiatives while the CEO has bought 480,000 shares. The market cap is $69.5M and the shares trade near their 52-week low at $2.95. Technical indicators show fading momentum but a bullish MACD histogram; short interest and short-volume are elevated. This trade …
Renault's recent Strategy Day delivered clearer product cadence, cost-out targets and capital allocation priorities that, if executed, should lift margins and re-rate the stock. Financial detail was limited in the materials reviewed, but the strategic priorities and potential catalysts justify a mid-term long trade with disciplined stops.
Meta Platforms ($META) is trading below its recent trend and looks like the most attractively priced member of the large-cap AI/tech cohort. With a $1.61T market cap, free cash flow of $46.1B and a trailing P/E around 27, the company offers durable ad revenue growth from its Family of Apps and heavy leverage to the AI infrastructure buildout via Re…
Mosaic (MOS) is a leveraged, cash-generative fertilizer producer that just picked up a strategic optionality with a rare-earths project in Brazil. Near-term fertilizer market tightening and limited Chinese exports set a bullish backdrop; the Uberaba partnership adds a multi-year upside that could justify a re-rating. Trade setup: enter $31.90, stop…
Aquestive collapsed after an FDA letter flagged deficiencies in the Anaphylm NDA. The market priced in a painful outcome; the balance sheet and upcoming investor events give a path to rehypothecated upside if management can show a credible fix or timeline. This is a speculative, mid-term swing trade with asymmetric upside vs. controlled downside.
Berkshire Hathaway offers a defensive equity play in a market shaped by geopolitical shocks and elevated commodity volatility. With a $1.06T market capitalization, $373.3B of cash reported at year-end 2025, and a conservative balance sheet, the company is positioned to buy assets, return capital, or buffer underwriting losses. We recommend a long p…
Pagaya (PGY) is trading near $11 with a market cap of roughly $900M despite clear improvements in profitability, a $224.7M free cash flow run-rate, and valuation multiples that look conservative for a profitable AI fintech. This trade idea lays out why the company’s pivot to an asset-light model, solid margins and attractive capital returns justify…
Uber's strategic tie-up with Zoox reframes autonomous vehicles as a revenue expansion lever for ride-hailing and delivery, not an existential threat. Strong cash generation, improving margins and a reasonable multiple give the stock room to re-rate. This trade targets a tactical long with defined entry, stop and upside targets over the next 45 trad…
Infosys (INFY) is a high-quality IT services franchise with a $54.5B market cap, a 3.27% yield and a trailing PE of 17.3. Fundamental stability, recurring outsourcing contracts and recent wins make the equity worth owning at current levels, but currency risk is the key caveat. This trade prescribes a long ADS position with a clear entry, stop and t…
B2Gold reported record revenue and ounces sold in 2025 but guided lower production and much higher all-in sustaining costs for 2026, a combination that sparked a selloff. The market reaction creates a tactical long opportunity: the shares already discount weaker near-term performance while the balance sheet, diversified assets and recent mine ramp-…
PagSeguro is trading at a low-teens multiple with a $2.73B market cap and a lean balance of payments products. With Brazil potentially moving toward easier monetary policy and credit penetration still expanding, PagSeguro could earn a re-rating. This trade targets a move to a mid-teens PE within 180 trading days while keeping a defined stop to cont…
Arista looks set to break higher after a period of consolidation around its 10/20/50-day moving averages. Strong Q4 results, raised 2026 guidance and a sizable deferred revenue backlog support the earnings runway; technicals show bullish momentum and below-average days-to-cover short interest reduces headline risk. This trade idea recommends a mid-…
BlackBerry's transformation from devices to software and security has been long and uneven. With Q3 revenue of $141.8M and adjusted EPS of $0.05 (reported 12/19/2025), an enterprise value near $2.0B and free cash flow of $42.9M, the stock at $3.43 today looks priced for slow growth. If QNX can meaningfully penetrate adjacent IoT verticals beyond au…
Daqo New Energy (DQ) looks like a classic cyclical turnaround: utilization recovering, management buying shares back and a deeply discounted market cap. This trade idea lays out a mid-term long with an entry at $23.50, a $31.00 target and a $19.00 stop, backed by operational and policy catalysts while clearly flagging the industry-level risks that …
SCZ (iShares MSCI EAFE Small-Cap ETF) offers targeted exposure to non-U.S. small caps trading below their short-term moving averages, with a 2.6% yield, a market cap of roughly $13.4B and valuation metrics that read as reasonable. Technicals are oversold (RSI ~30) and price sits near $79. A measured long trade for the next 45 trading days balances …
Shift4 (FOUR) has been cut roughly in half from its highs, trading near its 52-week low while reporting strong revenue growth and solid free cash flow. Technical oversold conditions, concentrated short interest and recent institutional buying create an asymmetric risk/reward for a recovery trade. This note lays out an actionable mid-term trade plan…
Shift4 has tumbled from its 52-week high while keeping solid revenue and cash generation. At current levels the stock offers a recovery asymmetric versus larger incumbents, but operational and leadership questions remain. This piece lays out a concrete long trade, catalysts to watch, and the risks that would flip the thesis.
Copart's shares have been hammered after a string of weaker prints and a visible derating from 52-week highs. Fundamentals remain intact - cash flow is strong, ROE is healthy and the market cap is now roughly $32.7B - creating a favorable entry after technical oversold readings. We upgrade to Buy and lay out entry, stop, and target for a mid-term/s…
enGene (ENGN) is a clinical-stage developer of DDX non-viral gene-delivery technology. With a market cap around $487M, low reported float (~48M shares), a history of financing at $10/share, and upcoming 2026 operational catalysts likely tied to trials and regulatory activity, the stock offers an asymmetric risk-reward for a disciplined long trade. …
GE Vernova (GEV) is a high-quality energy-industrial play with a deep backlog, improving free cash flow and strong ROE. Valuation looks rich on headline multiples, but the combination of a $150B-plus backlog, $3.71B in free cash flow and structural demand from data center electrification supports upside to $1,000 over the next 180 trading days. Ent…
Nvidia’s position in AI infrastructure continues to deepen: dominant share of AI accelerators, massive ecosystem commitments to suppliers and partners, and strong free cash flow give the company optionality to control the stack. Technicals and short-term macro risks argue for careful sizing, but over a 180-trading-day horizon the case for a long re…
Ultrapar (UGPA3) is a Brazil-focused downstream and chemicals player whose asset mix is positioned to benefit materially from outsized refining margins. With global 3-2-1 crack spreads near $40/bbl and theoretical industry windfalls approaching $240B annually, Ultrapar's retail, fuels distribution and terminals business should see step-change cash …
Nvidia's strategic tie-up with Palantir creates a credible pathway for government-grade, data-sovereign AI deployments. That should accelerate sales of Blackwell hardware, DGX/Cloud services and higher-margin software bundles, making the partnership a potential multi-quarter revenue and margin catalyst. Trade plan: enter $183.60, target $250.00, st…
Interim data and a favorable regulatory backdrop have increased the probability Solid Biosciences can start its next clinical trial in Q1 2026. The shares are trading below $8 with a market cap near $600M, leaving room for a re-rate if the company executes. This trade idea lays out a long entry, stop, targets and the risks to watch across a 46-180 …
